SCHEDULE 13G/AFiled May 17, 8:00 PM ET

Stoke Therapeutics, Inc. SCHEDULE 13G/A

Lynx1 Capital Management LP

Summary not available

This filing does not have a generated research summary. You can still open the original filing and its exhibits.